Carbylan Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Carbylan Therapeutics Inc
TickerKALV
CIK #0001348911
CUSIP483497103
SectorLife Sciences - Pharmaceutical Preparations
Address3181 Porter Drive, Palo Alto, CA 94304
Source [EDGAR]
CIK Filing 2011 - 2025
[0001348911] 10-K
[0001348911] 10-Q
[0001348911] 3
[0001348911] 4
[0001348911] 8-K
[0001348911] D
[0001348911] SC 13D
[0001348911] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vestal Point Capital LP KalVista Pharmaceuticals Inc [2024-11-14] 0.3
Capital World Investors KalVista Pharmaceuticals Inc [2024-11-13] 7.8
Adage Capital Partners GP LLC KalVista Pharmaceuticals Inc [2024-02-26] 6.87
Vanguard Group Inc KalVista Pharmaceuticals Inc [2024-02-13] 5.15
Saturn V Capital Management LP KalVista Pharmaceuticals Inc [2024-02-12] 4.1
BlackRock Inc KalVista Pharmaceuticals Inc [2024-01-29] 6.5
Suvretta Capital Management LLC KalVista Pharmaceuticals Inc [2023-03-10] 5.3
FMR LLC KalVista Pharmaceuticals Inc [2023-02-09] 0.0
TCG Crossover GP I LLC KalVista Pharmaceuticals Inc [2023-01-09] 0.9
Venrock Healthcare Capital Partners III LP KalVista Pharmaceuticals Inc [2023-01-09] 8.6
Tang Capital Partners LP KalVista Pharmaceuticals Inc [2022-05-26] 5.7
Great Point Partners LLC KalVista Pharmaceuticals Inc [2022-05-18] 5.22
Wellington Management Group LLP KalVista Pharmaceuticals Inc [2022-02-04] 7.4
Franklin Resources Inc KalVista Pharmaceuticals Inc [2022-02-04] 5.1
Frazier Life Sciences Public Fund LP KalVista Pharmaceuticals Inc [2021-12-30] 1.7
Deep Track Capital LP KalVista Pharmaceuticals Inc [2021-10-25] 5.18
Suvretta Capital Management LLC KalVista Pharmaceuticals Inc [2021-09-17] 5.3
RA Capital Management LP KalVista Pharmaceuticals Inc [2021-05-27] 5.7
Flynn James E KalVista Pharmaceuticals Inc [2021-05-07] 7.43
BlackRock Inc KalVista Pharmaceuticals Inc [2021-02-02] 6.2
Ikarian Capital LLC KalVista Pharmaceuticals Inc [2020-03-23] 5.3
FMR LLC KalVista Pharmaceuticals Inc [2020-02-07] 0.0
Flynn James E KalVista Pharmaceuticals Inc [2019-04-19] 7.06
Vivo Ventures VI LLC KalVista Pharmaceuticals Inc [2018-09-12] 2.1
Venrock Healthcare Capital Partners II LP KalVista Pharmaceuticals Inc [2018-08-09] 0.5
Eventide Asset Management LLC KalVista Pharmaceuticals Inc [2018-02-12] 6.6
Longwood Fund II LP KalVista Pharmaceuticals Inc [2017-10-20] 8.7
Merck & Co Inc KalVista Pharmaceuticals Inc [2017-10-16] 0.9
RA Capital Management LLC KalVista Pharmaceuticals Inc [2017-02-14] 6.0
SVLSF IV LLC KalVista Pharmaceuticals Inc [2017-02-07] 26.6
Novo A/S KalVista Pharmaceuticals Inc [2016-11-30] 29.2
KalVista Pharmaceuticals Ltd Carbylan Therapeutics Inc [2016-06-27] 52.97
Franklin Resources Inc Carbylan Therapeutics Inc [2016-02-04] 5.5
Price T Rowe Associates Inc /MD/ Carbylan Therapeutics Inc [2015-05-11] 10.7
FMR LLC Carbylan Therapeutics Inc [2015-05-11] 0.0
Vivo Ventures VI LLC Carbylan Therapeutics Inc [2015-04-24] 16.0
ACP IV LP Carbylan Therapeutics Inc [2015-04-24] 16.6
InterWest Partners IX LP Carbylan Therapeutics Inc [2015-04-21] 11.0
Broadfin Capital LLC Carbylan Therapeutics Inc [2015-04-14] 5.2
Form 3/4/5 Filer 2011 - 2025
KalVista Pharmaceuticals, Inc.
Palleiko Benjamin L
Audhya Paul K.
Yea Christopher
Shah Nimish P
Koh Bong Y
Venrock Healthcare Capital Partners III, L.P.
VHCP Co-Investment Holdings III, LLC
VHCP Management III, LLC
VHCP Management EG, LLC
Venrock Healthcare Capital Partners EG, L.P.
Piekos Brian
Reid Laurence
Fairey William
Pereira Brian JG
Stuart Nancy
Treanor Patrick
Unkart Edward W
Feener Edward P.
Crockett Thomas Andrew
Cha Albert
Smith Michael David
Edwards Martin
Soland Daniel B
Maetzel Andreas
Oronsky Arnold L
SVLSF IV LLC
SV Life Sciences Fund IV Strategic Partners L P
SV Life Sciences Fund IV LP
SV Life Sciences Fund IV (GP), L.P.
VHCP Co-Investment Holdings II, LLC
VHCP Management II, LLC
Venrock Healthcare Capital Partners II, L.P.
Aldrich Richard
Shah Rajeev M.
RA Capital Management LP
Kolchinsky Peter
Novo Holdings A/S
Resnick Joshua
RA Capital Healthcare Fund LP
Renzi David
Basta Steven L
Maroney Marcee
Saul David Joseph
Gravett David M.
Ramiya Premchandran
McKune John
Lewis Hayley
Katkin Keith
Clapper David M
Zadno Reza
Vivo Ventures VI, LLC
Vivo Ventures VI Affiilates Fund LP
Vivo Ventures Fund VI, L.P.
Kliman Gilbert H
InterWest Partners IX, LP
InterWest Management Partners IX, LLC
Nasr Khaled
Gianos Philip T
Pepper Douglas A
Cleveland Bruce A
Holmes W Stephen
Kjellson Nina S
Janney Daniel
ACP IV LP
ACMP IV LLC
Nohra Guy P
White Thomas Michael
Form 13F Holdings
Firm Period DFND Voting Shares
VR Adviser LLC [2025-06-30] SOLE 6,728,985 6,728,985
Suvretta Capital Management LLC [2025-06-30] SOLE 4,955,000 4,955,000
Tang Capital Management LLC [2025-06-30] OTR 0 4,941,798
Frazier Life Sciences Management LP [2025-06-30] SOLE 4,887,867 4,887,867
Vestal Point Capital LP [2025-06-30] SOLE 4,675,000 4,675,000
Capital World Investors [2025-06-30] DFND 3,177,587 3,177,587
BlackRock, Inc. [2025-06-30] SOLE 3,053,287 3,129,494
Vanguard Group Inc [2025-06-30] SOLE 0 2,363,261
Woodline Partners LP [2025-06-30] SOLE 1,920,664 1,920,664
SilverArc Capital Management LLC [2025-06-30] SOLE 1,832,171 1,832,171
State Street Corp [2025-06-30] DFND 1,302,204 1,349,539
Octagon Capital Advisors LP [2025-06-30] SOLE 1,273,333 1,273,333
Emerald Advisers LLC [2025-06-30] SOLE 776,347 1,038,049
Ameriprise Financial Inc [2025-06-30] DFND 0 945,125
Geode Capital Management LLC [2025-06-30] DFND 941,212 941,212
Emerald Mutual Fund Advisers Trust [2025-06-30] SOLE 768,972 768,972
Parkman Healthcare Partners LLC [2025-06-30] SOLE 679,063 679,063
Ikarian Capital LLC [2025-06-30] SOLE 598,528 598,528
DAFNA Capital Management LLC [2025-06-30] SOLE 581,757 581,757
Susquehanna International Group LLP [2025-06-30] OTR 294,198 564,798
Schroder Investment Management Group [2025-06-30] SOLE 554,958 554,958
Millennium Management LLC [2025-06-30] SOLE 340,629 430,629
Stempoint Capital LP [2025-06-30] SOLE 345,273 386,790
Bank of America Corp /DE/ [2025-06-30] DFND 16,207 366,966
Northern Trust Corp [2025-06-30] DFND 346,317 346,317
Great Point Partners LLC [2025-06-30] SOLE 0 323,170
Citigroup Inc [2025-06-30] DFND 299,194 299,194
PanAgora Asset Management Inc [2025-06-30] SOLE 148,097 292,593
Boothbay Fund Management LLC [2025-06-30] OTR 0 291,827
UBS Group AG [2025-06-30] DFND 272,856 272,861
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com